Target intelligence / Profile preview

Nicotinic Acetylcholine Receptor Neuronal α3β2 Subtype (nAChR α3β2)

Target
nAChR α3β2
Molecular classification
Ligand-gated ion channel, Receptor
01

Overview

The nicotinic acetylcholine receptor (nAChR) is a ligand-gated ion channel. The neuronal α3β2 subtype is a heteromeric nAChR, composed of alpha-3 (α3) and beta-2 (β2) subunits. These receptors mediate fast synaptic transmission by allowing cations to flow across the cell membrane upon activation by acetylcholine or nicotine. In neurons, activation leads to depolarization and can trigger action potentials or modulate neurotransmitter release. They are distributed throughout the CNS and PNS, with notable presence in autonomic ganglia and specific brain regions. Dysfunctional neuronal nAChRs have been implicated in diseases including Alzheimer’s disease, schizophrenia/autism spectrum disorders, neuropathic pain, and addiction.

02

Mechanism of action

Activation of the receptor leads to influx of cations (Na⁺, K⁺, Ca²⁺) across the cell membrane, causing depolarization and potentially triggering action potentials or modulating neurotransmitter release.

03

Biological functions

Fast excitatory neurotransmissionModulation/release of other neurotransmittersSynaptic transmission
04

Disease associations

Alzheimer’s diseaseSchizophreniaAutism spectrum disordersNeuropathic painAddictionNeuropsychiatric disorders
05

Safety considerations

Potential for off-target effects due to the diversity of nAChR isoforms.Challenges in achieving subtype-selective targeting.
06

Interacting drugs

Acetylcholine

2 more in the full profile.

Beyond the preview

Go deeper on Nicotinic Acetylcholine Receptor Neuronal α3β2 Subtype (nAChR α3β2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinic Acetylcholine Receptor Neuronal α3β2 Subtype (nAChR α3β2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call